Regulatory T cells expressing PD1/TIM3 are increased in leukemic bone marrow and AML blasts have been found to express PDL1, making T cell harnessing through checkpoint inhibitors (CPI) an attractive therapeutic strategy in AML [119]. The gene discussed is CD274; the disease is acute myeloid leukemia.